| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Embl Technology Fund II Gmbh & Co. Kg is a 10% Owner at X4 Pharmaceuticals, Inc. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $426K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2017 | XFOR X4 Pharmaceuticals, Inc | 10% Owner | Buy | 20,000 | $10.00 | $200,000.00 | +5.7% |